← Leaderboards
Christopher Chad Quarles
University Of Tx Md Anderson Can Ctr
$12,985,497
Attributed
$17,868,860
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,868,860 · 11
By mechanism
R01$14,193,619 · 6
R61$2,123,277 · 1
R00$747,000 · 1
UG3$364,296 · 1
R21$309,610 · 1
K99$131,058 · 1
Top collaborators
- Jerrold L Boxerman7 shared
- Leland Hu7 shared
- Kathleen Marie Schmainda7 shared
- Vikram D. Kodibagkar4 shared
- Thomas E Yankeelov4 shared
- Ashley M Stokes1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Marina Y Konopleva$11,210,192
Others in their field
Top investigators on “Magnetic Resonance Imaging”
- Michael W Weiner · Northern California Institute Res &Educ$151,227,246
- Paul S. Aisen · Cognition Therapeutics, Inc.$114,102,468
- Reisa A. Sperling · Banner Health$112,709,449
- Randall J Bateman · Washington University$108,056,165
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
Magnetic Resonance ImagingImageTumorResponseProtocols DocumentationGliomaPredispositionBrain NeoplasmsValidationContrast MediaPerfusionTissuesClinical TrialsTreatment ResponseHealthcareBaseBlood VesselsBiopsySiteAftercareMapsTreatment EffectRadiation TherapyContrast Enhanced
Grant awards (44)
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy$1,877,237
R01 · FY2025 · CA · contact PI
One-shot morphologic, hemodynamic and metabolic MR imaging of brain tumors$589,526
R01 · FY2025 · CA
Establishing the clinical utility of a consensus DSC-MRI Protocol$556,160
R01 · FY2025 · CA · contact PI
Relaxivity Contrast Imaging as Biomarker of Muscle Degeneration in ALS$627,541
R61 · FY2024 · NS · contact PI
Establishing the Validity of Brain Tumor Perfusion Imaging$338,006
R01 · FY2024 · CA · contact PI
Establishing the clinical utility of a consensus DSC-MRI Protocol$1
R01 · FY2024 · CA · contact PI
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy$1
R01 · FY2024 · CA · contact PI
Relaxivity Contrast Imaging as Biomarker of Muscle Degeneration in ALS$686,517
R61 · FY2023 · NS · contact PI
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy$647,029
R01 · FY2023 · CA · contact PI
Establishing the clinical utility of a consensus DSC-MRI Protocol$617,853
R01 · FY2023 · CA · contact PI
One-shot morphologic, hemodynamic and metabolic MR imaging of brain tumors$577,735
R01 · FY2023 · CA
Establishing the Validity of Brain Tumor Perfusion Imaging$369,886
R01 · FY2023 · CA · contact PI
Relaxivity Contrast Imaging as Biomarker of Muscle Degeneration in ALS$809,219
R61 · FY2022 · NS · contact PI
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy$684,353
R01 · FY2022 · CA · contact PI
Establishing the clinical utility of a consensus DSC-MRI Protocol$681,274
R01 · FY2022 · CA · contact PI
One-shot morphologic, hemodynamic and metabolic MR imaging of brain tumors$577,735
R01 · FY2022 · CA
Establishing the validity of brain tumor perfusion imaging$319,902
R01 · FY2022 · CA · contact PI
One-shot morphologic, hemodynamic and metabolic MR imaging of brain tumors$603,776
R01 · FY2021 · CA
MRI Assessment of Tumor Perfusion, Permeability and Cellularity$399,483
R01 · FY2021 · CA · contact PI
Establishing the validity of brain tumor perfusion imaging$394,763
R01 · FY2021 · CA · contact PI
MRI Assessment of Tumor Perfusion, Permeability and Cellularity$399,483
R01 · FY2020 · CA · contact PI
Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer$364,296
UG3 · FY2020 · CA · contact PI
Establishing the validity of brain tumor perfusion imaging$275,927
R01 · FY2020 · CA · contact PI
Multi-site Validation and Application of a Consensus DSC MRI Protocol$124,268
R01 · FY2020 · CA · contact PI
MRI Assessment of Tumor Perfusion, Permeability and Cellularity$387,498
R01 · FY2019 · CA · contact PI
Multi-site Validation and Application of a Consensus DSC MRI Protocol$317,574
R01 · FY2019 · CA · contact PI
Establishing the validity of brain tumor perfusion imaging$264,898
R01 · FY2019 · CA · contact PI
MRI Assessment of Tumor Perfusion, Permeability and Cellularity$405,817
R01 · FY2018 · CA · contact PI
Multi-site Validation and Application of a Consensus DSC MRI Protocol$295,825
R01 · FY2018 · CA · contact PI
Establishing the validity of brain tumor perfusion imaging$270,339
R01 · FY2018 · CA · contact PI
MRI Assessment of Tumor Perfusion, Permeability and Cellularity$392,185
R01 · FY2017 · CA · contact PI
Establishing the validity of brain tumor perfusion imaging$267,668
R01 · FY2017 · CA · contact PI
MRI Assessment of Tumor Perfusion, Permeability and Cellularity$316,034
R01 · FY2015 · CA · contact PI
MRI Assessment of Tumor Perfusion, Permeability and Cellularity$1,159
R01 · FY2015 · CA · contact PI
MRI Assessment of Tumor Perfusion, Permeability and Cellularity$307,677
R01 · FY2014 · CA · contact PI
MRI Assessment of Tumor Perfusion, Permeability and Cellularity$298,161
R01 · FY2013 · CA · contact PI
MRI Assessment of Tumor Perfusion, Permeability and Cellularity$317,193
R01 · FY2012 · CA · contact PI
MRI Assessment of Tumor Perfusion, Permeability and Cellularity$317,193
R01 · FY2011 · CA · contact PI
Quantitative MRI Assessment of Tumor Hypoxia and Angiogenesis$249,000
R00 · FY2010 · CA · contact PI
Quantitative MRI Assessment of Tumor Hypoxia and Angiogenesis$249,000
R00 · FY2009 · CA · contact PI
Quantitative MRI Assessment of Tumor Hypoxia and Angiogenesis$249,000
R00 · FY2008 · CA · contact PI
Quantitative MRI Assessment of Tumor Vascular and Oxygen Reactivity$184,200
R21 · FY2008 · CA · contact PI
Quantitative MRI Assessment of Tumor Hypoxia and Angiogenesis$131,058
K99 · FY2007 · CA · contact PI
Quantitative MRI Assessment of Tumor Vascular and Oxygen Reactivity$125,410
R21 · FY2007 · CA · contact PI